We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » $64 Billion Market Predicted by 2016 for Pharma Contract Manufacturing
$64 Billion Market Predicted by 2016 for Pharma Contract Manufacturing
September 8, 2011
Global revenues for contract pharma manufacturing will exceed $64 billion in 2016, according to London-based business analysis company visiongain. Driving that growth will be production of finished dosage forms, the company’s report, Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021, states.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor